China
Wu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical patent litigation cases is set to be used in re-examination and invalidation proceedings after the CNIPA makes an invalidation decision a quasi-precedent
Maohua Wang, head of the IP group at King & Wood Mallesons in China, explains how the firm’s Eversheds deal affected the IP team and how his team meets clients’ litigation needs
Wu Xiaohui of Wanhuida Intellectual Property explains why a recent decision on inventiveness assessments of co-solvent compound crystals heralds a significant shift in focus by the CNIPA, with implications for pharmaceutical patent strategies
Loeb & Loeb has taken on the IP, corporate and compliance teams from Perkins Coie’s soon-to-be closed Beijing office
Sponsored
Sponsored
-
Sponsored by Tahota Law FirmCharles Feng of Tahota Law Firm begins a two-part guide to intellectual property protection in China by considering the general provisions, before focusing on the key issues and legal framework concerning trademarks -
Sponsored by Tahota Law FirmCharles Feng of Tahota Law Firm concludes a two-part series on intellectual property protection in China by looking at copyright, unfair competition, and a change to the appeals procedure for technology-related disputes
-
Sponsored by Tahota Law FirmIn the first article of a two-part series, Charles Feng, Lian Xue, and Runjing Wang of Tahota Law Firm consider the different perspectives on whether China’s Anti-Unfair Competition Law should regulate internet advertising blocking
-
Sponsored by Tahota Law FirmA two-part series concludes with Charles Feng, Lian Xue, and Runjing Wang of Tahota Law Firm analysing relevant Chinese case law in assessing whether the mobile application LiTiaotiao constitutes unfair competition
-
Sponsored by Liu Shen & AssociatesXuelan Yue of Liu Shen & Associates draws on several ‘model cases’ put forward by the Intellectual Property Court of the Supreme People’s Court of China to highlight trends in trade secret infringement cases
-
Sponsored by Wanhuida Intellectual PropertyA ruling on the inventiveness of a compound patent for a prostate cancer therapeutic could help create uniform jurisprudence regarding the examination of pharmaceutical patents, says Guan Yue of Wanhuida Intellectual Property
